Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, AIDS, vol.23, issue.4, pp.525-530, 2009. ,
Hidden killers: human fungal infections, Sci Transl Med, vol.4, issue.165, pp.165-178, 2012. ,
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis, Lancet Infect Dis, vol.17, issue.8, pp.873-881, 2017. ,
Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types, Scientifica (Cairo), p.675213, 2013. ,
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med, vol.4, p.19760, 2014. ,
Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex, Fungal Genet Biol, vol.78, pp.16-48, 2015. ,
Cryptococcus: from environmental saprophyte to global pathogen, Nat Rev Microbiol, vol.14, issue.2, pp.106-117, 2016. ,
IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates, Emerg Infect Dis, vol.9, issue.2, pp.189-195, 2003. ,
The biology of the Cryptococcus neoformans species complex, Annu Rev Microbiol, vol.60, pp.69-105, 2006. ,
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay, PLoS One, vol.12, issue.6, p.178721, 2017. ,
Cryptococcal meningitis: epidemiology and therapeutic options, Clin Epidemiol, vol.6, pp.169-182, 2014. ,
, UNAIDS. Country factsheets Madagascar, 2017.
Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid, Clin Vaccine Immunol, vol.20, issue.1, pp.52-55, 2013. ,
Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test, J Acquir Immune Defic Syndr, vol.45, issue.4, pp.380-388, 2007. ,
Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings, J Clin Pathol, vol.69, issue.4, pp.352-357, 2016. ,
International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database-the quality controlled standard tool for routine identification of human and animal pathogenic fungi, Med Mycol, vol.53, issue.4, pp.313-337, 2015. ,
MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex, PloS One, vol.7, issue.5, p.37566, 2012. ,
Determination of Cryptococcus neoformans var. neoformans mating type by multiplex PCR, Clin Microbiol Infect, vol.10, issue.12, p.15606637, 2004. ,
Genotyping Cryptococcus neoformans var. neoformans with specific primers designed from PCR-fingerprinting bands sequenced using a modified PCRbased strategy, Med Mycol, vol.38, issue.2, pp.97-103, 2000. ,
Molecular-type specific multiplex PCR produces a distinct VNII PCR pattern among Cryptococcus neoformans species complex, Med Mycol, vol.57, issue.3, pp.384-386, 2019. ,
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine, Antimicrob Agents Chemother, vol.56, issue.6, pp.3107-3113, 2012. ,
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole, Antimicrob Agents Chemother, vol.56, issue.11, pp.5898-5906, 2012. ,
Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio, BMC Res Methodol, vol.20, pp.3-21, 2003. ,
Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)-positive human immunodeficiency virus-infected persons in an Ethiopian CrAg screening program, Clin Infect Dis, vol.65, issue.12, pp.2126-2129, 2017. ,
,
, J Mycol Med, vol.27, issue.1, pp.72-78, 2017.
Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study, J Int AIDS Soc, vol.14, p.48, 2011. ,
, Guidelines for The Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection, World Health Organization, 2018.
Rapid fatal outcome of cryptococcal meningoencephalitis in a non-HIV immunocompromised patient with a low fluconazole susceptibility isolate: a case report from Madagascar. Case Rep, Infect. Dis, p.3492504, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01470799
Identification and characterization of VNI/VNII and novel VNII/VNIV hybrids and impact of hybridization on virulence and antifungal susceptibility within the C. neoformans/C. gattii species complex, PLoS One, vol.11, issue.10, p.163955, 2016. ,